Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Moodys
Teva
Julphar
UBS
US Department of Justice
Chinese Patent Office
Chubb
Merck

Generated: February 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR KLONOPIN

« Back to Dashboard

Clinical Trials for Klonopin

Trial ID Title Status Sponsor Phase Summary
NCT00652639 Bioavailability Study of Clonazepam Tablets Under Fasting Conditions Completed Cetero Research, San Antonio Phase 1 To compare the single-dose bioavailability of Clonazepam tablets 1 mg and Klonopin tablets 1 mg
NCT00652639 Bioavailability Study of Clonazepam Tablets Under Fasting Conditions Completed Par Pharmaceutical, Inc. Phase 1 To compare the single-dose bioavailability of Clonazepam tablets 1 mg and Klonopin tablets 1 mg
NCT00652912 Bioavailability Study of Clonazepam ODT Under Fasting Conditions Completed Gatway Medical Research, Inc Phase 1 To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT
NCT00652912 Bioavailability Study of Clonazepam ODT Under Fasting Conditions Completed Par Pharmaceutical, Inc. Phase 1 To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT
NCT01700829 Ketamine in the Treatment of Suicidal Depression Recruiting National Institute of Mental Health (NIMH) Phase 4 This study is designed to compare the effectiveness of two medications, Ketamine and Midazolam, for rapidly relieving suicidal thoughts in people suffering from depression. The first drug, Ketamine, is an experimental antidepressant that early studies have shown may quickly reduce suicidal thoughts, but we are not sure how well it may work. Midazolam, the comparison drug, is not thought to reduce depression or suicidal thoughts.
NCT01700829 Ketamine in the Treatment of Suicidal Depression Recruiting New York State Psychiatric Institute Phase 4 This study is designed to compare the effectiveness of two medications, Ketamine and Midazolam, for rapidly relieving suicidal thoughts in people suffering from depression. The first drug, Ketamine, is an experimental antidepressant that early studies have shown may quickly reduce suicidal thoughts, but we are not sure how well it may work. Midazolam, the comparison drug, is not thought to reduce depression or suicidal thoughts.
NCT01944293 Ketamine for Suicidality in Bipolar Depression Recruiting Brain & Behavior Research Foundation Phase 1/Phase 2 This study is designed to compare the effectiveness of two medications, Ketamine and Midazolam, for rapidly relieving suicidal thoughts in people suffering from bipolar depression. The first drug, ketamine, is an experimental antidepressant that early studies have shown may quickly reduce suicidal thoughts, but we are not sure how well it may work. Midazolam, the comparison drug, is not thought to reduce depression or suicidal thoughts.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Klonopin

Condition Name

Condition Name for Klonopin
Intervention Trials
Suicidal Ideation 2
To Determine Bioequivalence Under Fasting Conditions 2
Burning Mouth Syndrome 1
Bipolar Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Klonopin
Intervention Trials
Disease 3
Suicidal Ideation 2
Depressive Disorder, Major 2
Depression 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Klonopin

Trials by Country

Trials by Country for Klonopin
Location Trials
United States 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Klonopin
Location Trials
New York 2
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Klonopin

Clinical Trial Phase

Clinical Trial Phase for Klonopin
Clinical Trial Phase Trials
Phase 4 3
Phase 1/Phase 2 1
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Klonopin
Clinical Trial Phase Trials
Completed 2
Recruiting 2
Not yet recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Klonopin

Sponsor Name

Sponsor Name for Klonopin
Sponsor Trials
New York State Psychiatric Institute 2
Par Pharmaceutical, Inc. 2
University of Alberta 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Klonopin
Sponsor Trials
Other 9
Industry 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
Chubb
Chinese Patent Office
AstraZeneca
Express Scripts
Queensland Health
Medtronic
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.